Skip to main content
. Author manuscript; available in PMC: 2014 Jan 3.
Published in final edited form as: J Prim Care Community Health. 2013 May 12;4(4):10.1177/2150131913487561. doi: 10.1177/2150131913487561

Table 2.

Proficiency Test Program Totals by Product for 2010 and 2011.

Total Correct
(Percentage Correct)
Total Incorrect
(Percentage Incorrect)
Overall
Sensitivity
(95% CI)2
Overall
Specificity
(95% CI)2
Pos Neg Pos Neg
Beckman/Coulter Hemoccult ICT n = 1633 945 (98.2) 658 (98.1) 17 (1.8) 13 (1.9) 98.2% (97.2 to 98.9) 98.1% (96.7 to 98.9)
Hemosure IFOBT n = 1711 984 (94.4) 610 (91.2) 58 (5.6) 59 (8.8) 94.4% (92.9 to 95.7) 91.2% (88.8 to 93.1)
Immunostics Hema-Screen Specific n = 669 305 (98.1) 356 (99.4) 6 (1.9) 2 (0.6) 98.1% (95.8 to 99.2) 99.4% (97.8 to 1.0)
Inverness Clearview iFOB Complete1 n = 357 143 (87.2) 156 (80.8) 21 (12.8) 37 (19.2) 87.2% (81.1 to 91.5) 80.8% (74.7 to 85.8)
Inverness Clearview Ultra FOB n = 836 501 (91.6) 272 (94.1) 46 (8.4) 17 (5.9) 91.6% (88.9 to 93.7) 94.1 (90.7 to 96.4)
Polymedco OC-Light IFOB n = 976 562 (98.4) 398 (98.3) 9 (1.6) 7 (1.7) 98.4% (97.0 to 99.2) 98.3% (96.4 to 99.2)
Polymedco OC-Auto Micro 80 n = 586 340 (98.8) 241 (99.6) 4 (1.2) 1 (0.4) 98.8% (96.9 to 99.7) 99.6% (97.5 to 1.0)
Quidel QuickVue iFOB n = 1321 821 (98.3) 481 (99.0) 14 (1.7) 5 (1.0) 98.3% (97.2 to 99.0) 99.0% (97.5 to 99.6)
1

Taken off the market in 2011

2

95% Agresti-Coull binomial proportion confidence interval